{"entity":{"type":"insider","cik":"0001707000","url":"/insider/0001707000","json_url":"/insider/0001707000.json","name":"Sullivan Timothy Eugene","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":19,"first":"2019-09-03","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Sullivan Timothy Eugene","source":"filing","n_filings":19,"first_seen":"2019-09-03","last_seen":"2026-01-23"}],"transactions":[{"id":5800885,"accession":"0001492422-26-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000055","line_url":"/filing/0001492422-26-000055#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10287.0,"shares_display":"10,287","price_per_share":21.7654,"price_display":"21.77","price_state":"stated","total_value":223900.6698,"total_display":"223,900.67","total_whole":"223,901","shares_owned_after":93901.0,"shares_owned_after_display":"93,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":6054217,"accession":"0001492422-26-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000039","line_url":"/filing/0001492422-26-000039#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2892.0,"shares_display":"2,892","price_per_share":19.7929,"price_display":"19.79","price_state":"stated","total_value":57241.0668,"total_display":"57,241.07","total_whole":"57,241","shares_owned_after":104188.0,"shares_owned_after_display":"104,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":5755946,"accession":"0001492422-26-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000026","line_url":"/filing/0001492422-26-000026#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3856.0,"shares_display":"3,856","price_per_share":22.1872,"price_display":"22.19","price_state":"stated","total_value":85553.8432,"total_display":"85,553.84","total_whole":"85,554","shares_owned_after":107080.0,"shares_owned_after_display":"107,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":4782949,"accession":"0001492422-25-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001492422-25-000011","line_url":"/filing/0001492422-25-000011#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.03,"price_display":"28.03","price_state":"stated","total_value":280300.0,"total_display":"280,300.00","total_whole":"280,300","shares_owned_after":110936.0,"shares_owned_after_display":"110,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-21","filed_date":"2025-10-23","scope":"insider"},{"id":4989265,"accession":"0001127602-25-021248","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-25-021248","line_url":"/filing/0001127602-25-021248","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42729.0,"shares_display":"42,729","price_per_share":27.85297900723162,"price_display":"27.85","price_state":"stated","total_value":1190129.94,"total_display":"1,190,129.94","total_whole":"1,190,130","shares_owned_after":110936.0,"shares_owned_after_display":"110,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-10","scope":"insider","n_lines":2},{"id":5163973,"accession":"0001127602-25-002385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-002385","line_url":"/filing/0001127602-25-002385#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":546.0,"shares_display":"546","price_per_share":29.5236,"price_display":"29.52","price_state":"stated","total_value":16119.8856,"total_display":"16,119.89","total_whole":"16,120","shares_owned_after":128665.0,"shares_owned_after_display":"128,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":4030450,"accession":"0001127602-25-001843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001843","line_url":"/filing/0001127602-25-001843#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3088.0,"shares_display":"3,088","price_per_share":30.4255,"price_display":"30.43","price_state":"stated","total_value":93953.944,"total_display":"93,953.94","total_whole":"93,954","shares_owned_after":129211.0,"shares_owned_after_display":"129,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4141933,"accession":"0001127602-25-001627","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001627","line_url":"/filing/0001127602-25-001627#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1730.0,"shares_display":"1,730","price_per_share":29.9582,"price_display":"29.96","price_state":"stated","total_value":51827.686,"total_display":"51,827.69","total_whole":"51,828","shares_owned_after":86370.0,"shares_owned_after_display":"86,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":5044736,"accession":"0001127602-25-001202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001202","line_url":"/filing/0001127602-25-001202#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2170.0,"shares_display":"2,170","price_per_share":28.7021,"price_display":"28.70","price_state":"stated","total_value":62283.557,"total_display":"62,283.56","total_whole":"62,284","shares_owned_after":88100.0,"shares_owned_after_display":"88,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-14","scope":"insider"},{"id":2109528,"accession":"0001127602-24-011814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-011814","line_url":"/filing/0001127602-24-011814#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":58.66,"price_display":"58.66","price_state":"stated","total_value":234640.0,"total_display":"234,640.00","total_whole":"234,640","shares_owned_after":93338.0,"shares_owned_after_display":"93,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-02","scope":"insider"},{"id":2502527,"accession":"0001127602-24-008499","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-24-008499","line_url":"/filing/0001127602-24-008499","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":63.223333333333336,"price_display":"63.22","price_state":"stated","total_value":379340.0,"total_display":"379,340.00","total_whole":"379,340","shares_owned_after":95338.0,"shares_owned_after_display":"95,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider","n_lines":2},{"id":2172058,"accession":"0001127602-24-004721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-004721","line_url":"/filing/0001127602-24-004721#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1431.0,"shares_display":"1,431","price_per_share":67.7669,"price_display":"67.77","price_state":"stated","total_value":96974.4339,"total_display":"96,974.43","total_whole":"96,974","shares_owned_after":93338.0,"shares_owned_after_display":"93,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":2207197,"accession":"0001127602-24-002749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-002749","line_url":"/filing/0001127602-24-002749#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":906.0,"shares_display":"906","price_per_share":64.1382,"price_display":"64.14","price_state":"stated","total_value":58109.2092,"total_display":"58,109.21","total_whole":"58,109","shares_owned_after":94769.0,"shares_owned_after_display":"94,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":3067595,"accession":"0001127602-24-001956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-001956","line_url":"/filing/0001127602-24-001956#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3551.0,"shares_display":"3,551","price_per_share":64.996,"price_display":"65.00","price_state":"stated","total_value":230800.796,"total_display":"230,800.80","total_whole":"230,801","shares_owned_after":95675.0,"shares_owned_after_display":"95,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":2086697,"accession":"0001127602-24-001433","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-001433","line_url":"/filing/0001127602-24-001433#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2235.0,"shares_display":"2,235","price_per_share":66.8086,"price_display":"66.81","price_state":"stated","total_value":149317.221,"total_display":"149,317.22","total_whole":"149,317","shares_owned_after":99226.0,"shares_owned_after_display":"99,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":8149301,"accession":"0001127602-23-028592","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-028592","line_url":"/filing/0001127602-23-028592","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14158.0,"shares_display":"14,158","price_per_share":54.73119932193813,"price_display":"54.73","price_state":"stated","total_value":774884.32,"total_display":"774,884.32","total_whole":"774,884","shares_owned_after":78013.0,"shares_owned_after_display":"78,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-01","scope":"insider","n_lines":2},{"id":8625108,"accession":"0001127602-23-020394","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-23-020394","line_url":"/filing/0001127602-23-020394","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6779.0,"shares_display":"6,779","price_per_share":89.97316983330875,"price_display":"89.97","price_state":"stated","total_value":609928.1183,"total_display":"609,928.12","total_whole":"609,928","shares_owned_after":78013.0,"shares_owned_after_display":"78,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider","n_lines":3},{"id":8649741,"accession":"0001127602-23-018065","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-23-018065","line_url":"/filing/0001127602-23-018065","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69779.0,"shares_display":"69,779","price_per_share":88.80217338167644,"price_display":"88.80","price_state":"stated","total_value":6196526.8564,"total_display":"6,196,526.86","total_whole":"6,196,527","shares_owned_after":115283.0,"shares_owned_after_display":"115,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-06","scope":"insider","n_lines":4},{"id":8261545,"accession":"0001127602-19-027755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-19-027755","line_url":"/filing/0001127602-19-027755#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001707000","owner_name":"Sullivan Timothy Eugene","owner_display_name":"Sullivan Timothy Eugene","owner_url":"/insider/0001707000","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11699.0,"shares_display":"11,699","price_per_share":29.7145,"price_display":"29.71","price_state":"stated","total_value":347629.9355,"total_display":"347,629.94","total_whole":"347,630","shares_owned_after":11699.0,"shares_owned_after_display":"11,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-29","filed_date":"2019-09-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Officer (Chief Financial Officer)","n_filings":19,"first_seen":"2019-09-03","last_seen":"2026-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001707000","retrieved_at":"2026-08-24T13:43:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}